Hot Pursuit     09-Feb-21
Galaxy Surfactant Q3 PAT rises 78% to Rs 85 cr
On a consolidated basis, Galaxy Surfactants' net profit surged 77.6% to Rs 85.23 crore on 7.8% rise in net sales to Rs 674.70 crore in Q3 FY21 over Q3 FY20.
The specialty chemical maker said increase in revenue was on account of better sales volumes in both performance surfactants and specialty care business along with better sales mix. The chemical maker's consolidated total volume increased by 7.3% year on year to 58,238 MT.

Profit before tax surged 63.2% to Rs 103.22 crore in Q3 FY21 from Rs 63.23 crore in Q3 FY20. Current tax expense spiked 17.5% to Rs 18.7 crore in Q3 FY21 as against 15.91 crore in Q3 FY20.

EBITDA stood at Rs 122.5 crore, registering a 43% year on year growth, driven by increasing share of specialty, better product mix due to new products and higher capacity utilization. The board has declared interim dividend of Rs 14 per equity share.

Commenting on the performance U. Shekhar, MD of Galaxy Surfactants said, "If Q2 stood for recovery, Q3 stands for normalisation, sustenance and resumption of the growth trajectory. The robust momentum of Q2 has sustained in Q3. We are pleased to share that Q3 marks the 1st quarter in FY21 where the company has grown in every area, be it segments, regions or each of the financial parameters we measure ourselves on. This quarter also marks the first in FY21 where our Specialty Portfolio has registered Y-O-Y growth, arresting the underperformance reported in the last few quarters. Demand continues to remain robust for our performance surfactants, thus clearly highlighting the resilience and robustness of your company's business model. With the vaccination drive gaining traction, opening up of the economies with greater consciousness about health and hygiene should augur well for our performance, masstige as well premium specialty products. While demand continues to remain robust, rising volatility in raw material prices, supply chain disruptions pose the biggest risks in servicing this underlying demand. But, despite the challenges and none bigger than the one seen this year, we remain confident and optimistic about our growth journey."

Galaxy Surfactants is leading manufacturers of performance surfactants and specialty care products with over 205 product grades. These products are used in consumer-centric home and personal care products like hair care, oral care, skin care, cosmetics, soap, shampoo, lotion, detergent, cleaning products etc.

Galaxy Surfactant fell 0.02% to Rs 2268.15. Shares of Galaxy Surfactants hit a 52-week high of Rs 2,367.15 in intraday today.

Previous News
  Galaxy Surfactants consolidated net profit declines 14.39% in the March 2024 quarter
 ( Results - Announcements 22-May-24   07:32 )
  Galaxy Surfactants consolidated net profit declines 8.00% in the March 2023 quarter
 ( Results - Announcements 24-May-23   07:33 )
  Galaxy Surfactants consolidated net profit rises 6.04% in the June 2024 quarter
 ( Results - Announcements 09-Aug-24   07:32 )
  Galaxy Surfactants jumps as Q3 PAT soars 133% YoY
 ( Hot Pursuit - 13-Feb-23   13:05 )
  Galaxy Surfactants to convene board meeting
 ( Corporate News - 15-May-24   15:10 )
  Galaxy Surfactants fixes record date for final dividend
 ( Market Beat - Reports 22-Jul-19   17:21 )
  Volumes jump at Blue Star Ltd counter
 ( Hot Pursuit - 31-Oct-23   14:30 )
  Galaxy Surfactants Q2 PAT doubles to Rs 83-cr; performance surfactants volumes up 2.3% YoY
 ( Hot Pursuit - 10-Nov-22   13:46 )
  Galaxy Surfactants to table results
 ( Corporate News - 06-Aug-19   16:21 )
  Galaxy Surfactants slips after plants receive Form 483
 ( Hot Pursuit - 03-Apr-18   13:50 )
  Galaxy Surfactants announces board meeting date
 ( Corporate News - 01-Jun-21   10:01 )
Other Stories
  Avantel Q2 PAT jumps 42% YoY to Rs 23 cr
  05-Oct-24   17:03
  Equitas SFB total deposits jump 29% YoY in Q2 FY25
  05-Oct-24   16:28
  Ujjivan SFB total deposits rises 17% in Q2 FY25
  05-Oct-24   15:34
  L&T Finance retail disbursements jump 12% YoY in Q2 FY25
  05-Oct-24   14:31
  Bandhan Bank records over 21% YoY jump in loan book during Q2 FY25; deposits at Rs 1.42 lakh crore
  05-Oct-24   13:32
  Lupin's Pune-based biotech facility gets 5 observations from US FDA
  05-Oct-24   13:20
  Macrotech Developers pre-sales jumps 21% YoY in Q2 FY25
  05-Oct-24   09:04
  UCO Bank’s total advances jump 19% YoY in Q2 FY25
  04-Oct-24   15:15
  Vakrangee Ltd leads losers in 'A' group
  04-Oct-24   15:00
  Kamdhenu Ventures Ltd leads losers in 'B' group
  04-Oct-24   14:45
Back Top